Navigation Links
The U.S. Surgeon General Issues National Call-to-Action on Deep-Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
Date:9/15/2008

lth and to reduce their risk for illness or injury. When a health topic warrants special attention, the Surgeon General may issue a national Call-to-Action.

The Call-to-Action urges a coordinated, multifaceted plan to reduce the number of cases of DVT and PE nationwide. The plan emphasizes the need for:
-- Increased awareness about DVT and PE

-- Evidence-based practices for DVT

-- More research on the causes, prevention, and treatment of DVT.

The Call-to-Action resulted from a Surgeon General's workshop on DVT which was convened in May 2006. The workshop was co-sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. This workshop was funded by sanofi-aventis.

About Deep-Vein Thrombosis and Pulmonary Embolism

DVT occurs when a thrombus (blood clot) forms in one of the large veins, usually in the lower limbs, leading to either partially or completely blocked circulation. If left untreated, this clot has the potential to move into the lungs and block circulation to this vital organ creating a life threatening condition -- known as pulmonary embolism (PE) -- requiring immediate medical attention. Complications from DVT kill more people each year in the U.S. than breast cancer and AIDS combined.

Certain individuals may be at increased risk for developing DVT; however, it can occur in almost anyone. Additional risk factors include, but are not limited to restricted mobility, cancer, certain heart or respiratory diseases, major surgery, such as hip or knee replacements, advanced age, oral contraceptives or hormone therapy. It is important to consult your healthcare provider about the signs and symptoms associated with DVT. For more information, visit http://www.preventdvt.org.

About the Coalition to Prevent Deep-Vein Thrombosis

In February 2003, more than 60 organizations assembled at the Public He
'/>"/>

SOURCE Coalition to Prevent Deep-Vein Thrombosis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting
2. Mayo Clinic chest surgeons propose measures for indicating quality of lung surgery
3. Endocrinologists and surgeons join forces to fight type 2 diabetes
4. Former U.S. Assistant Surgeon General, Dr. Susan Blumenthal, to Lead Meridian International Centers Global Health Program
5. Orthopedic Surgeons Weigh in on Pool Safety
6. Communication gap exists between seniors and surgeons, study finds
7. Former U.S. Surgeon General Julius B. Richmond, 91
8. News briefs from the American Society of Plastic Surgeons
9. Trusted LASIK Surgeons Welcomes Top LASIK Expert Randy Epstein, M.D. of Chicago to it's Unique Lasik Directory Service
10. Surgeons Use USGI Medicals EndoSurgical Operating System to Complete Live Incisionless Appendectomy at Leading NOTES Conference
11. Nations Fourth Hand Transplant Performed at Jewish Hospital Hand Care Center by Kleinert Kutz and University of Louisville Surgeons

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...logy (EAU) and Europa Uomo, the European,advocacy...ave entered into an,affiliated partnership as par...prove,patient awareness in Europe with regards to...hamsson, Secretary-General of the EAU: "Thanks to ...mo will gain access to the latest information on,...
(Date:11/30/2009)...er knows the enormous joy and comfort that an anim... pets are considered important members of the fami... research now documents the value of the human-ani...l illness, physical impairment, dementia, abuse an...cerated youth and adults. , In two articles in a...
(Date:11/30/2009)...l has launched a series of clinical trials in orde...ment. This approach involves the application of pe...ur cells from the patient him or herself and desig...ssive and frequent malignant tumours. The new ther...ined with the standard, first-line treatment invol...
(Date:11/30/2009)... "My Two-Year Old Eats Octopus," gives m...everything. , (PRWEB) Nov...r house? Do you find yourself acting as a short-o...eos – one focusing on packing lunches, a sec...real-life parents’ questions – introdu...
(Date:11/30/2009)...me, so do knees, internal injuries, study finds, ...If you,re a middle-age weekend warrior who likes t...te: A new study suggests that high levels of physi...e that could lead to osteoarthritis. , The stud...eople who showed no symptoms and had a healthy wei...
Breaking Medicine News(10 mins):Health News:The therapeutic benefits of the human-animal bond 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3
...Corporation,(NYSE: SYK ) announced that it will h...7 at 4:30 p.m., Eastern Time, to discuss the Compa...mber 30, 2007 and provide an,operational update. O...Officer, Dean H.,Bergy, Vice President and Chief F...
...ncourages carcinogens, study suggests , THURSDAY, ... the stomach, vitamin C transforms from a cancer-f...w research suggests. , Researchers at Western Infi...ancerous changes and tumor growth. They focused o...
... Vall d,Hebron Hospital have diagnosed two patient...es coughing and difficulty in breathing due to irr...ce. Until now, medical literature had only describ...haling. Under normal conditions, the vocal cords w...
... briefs from,HealthFitness (OTC Bulletin Board: HF...evolving into employer partners to create a cultur...in/prnh/20070830/HFLOGO ) "Corporate America Emb...to address the high cost of health care,in a globa...
... Merger; Says ,Shareholders Have Already ...re, NEW YORK, Sept. 6 Elliott Associates, L.P.,(...jor shareholder of,Bioenvision (Nasdaq: BIVN ), t...e, 41st Floor New York, NY 10154, Dear Members ...
... Kris Carr is a photographer, director, produce... (TLC) documentary film "Crazy Sexy Can...er Tips." In 2003 Carr was diagnosed wi...rr became determined to find answers wh...
Other Medicine News:Health News:Stryker To Host Conference Call on October 17, 2007 2Health News:Vitamin C Plus Fat Might Spur Cancer 2Health News:Vocal cord dysfunction may be caused by work 2Health News:HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming 2Health News:HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming 3Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 2Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 3Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 4Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 5Health News:Author Kris Carr to Sign 'Crazy Sexy Cancer Tips' at Two Borders(R) Stores in California 2
(Date:11/30/2009)... , WAYNE, N.J. and CHICAGO, Nov. 30 /PRNewsw...Annual Meeting of the Radiological Society of No...ls Inc. announced the enrollment of the first pati...o evaluate the efficacy and safety of florbetaben ...-Amyloid plaques in the brain, which are a patholo...
(Date:11/30/2009)... , RICHMOND, Va., Nov. 30 I...nse with sanofi-aventis U.S. for a novel epinephri.... Under the license, sanofi-aventis U.S. shall be ...n. Intelliject will be responsible for the on-goin...proval and has retained certain co-promotion right...
(Date:11/30/2009)... , CHICAGO, Nov. 30 /PRNewswire-USNewswire/ -...isk ,, A new study from Cincinnati Children,s ...stay-tabs pose a potential ingestion risk. In the ... design after safety concerns about pull-tabs. The... a single institution, mainly among teenagers. Fur...
Breaking Medicine Technology:Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3Monday, Nov. 30: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Monday, Nov. 30: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3Despite Managed Care Obstacles Interest and Anticipated Use of Centocor Ortho Biotechs New Psoriasis Agent Stelara 28ustekinumab 29 is High 6544 1Despite Managed Care Obstacles Interest and Anticipated Use of Centocor Ortho Biotechs New Psoriasis Agent Stelara 28ustekinumab 29 is High 6544 2Vanderbilt scientists report first effective medical therapy for rare stomach disorder 62146 1Vanderbilt scientists report first effective medical therapy for rare stomach disorder 62146 2Hormone ghrelin can boost resistance to Parkinsons disease 10903 1Hormone ghrelin can boost resistance to Parkinsons disease 10903 2
...ovel siRNA Structures Exhibit Stability and Activi...maceuticals, Inc., a,clinical-stage biopharmaceuti...novel RNA interference-based therapeutics, announc...cation covering a number of novel,chemical modific... and,excellent penetration into the human cells te...
..., Aug. 27 CryoCor, Inc. (Nasdaq:,CRYO), a medical...c,arrhythmias, announced today the completion of e...eatment of atrial fibrillation. Ed Brennan, Ph.D....s a,major milestone for CryoCor, being the first c...tal study for the use of ablation for the treatmen...
Other Medicine Technology:Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules 2Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules 3CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation 2CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation 3
Cortex Extractor - Charleux
HydroExpression Cannula - Corydon
Hydrodissector - Pearce
Irrigating Cystotome
Medicine Products: